Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.589, 2009-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Insulin use, disease complications raise costs in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 429, 2003-01 ,pp. :
Access to resources
Recommend
Insulin therapy decreases long-term costs in type 2 DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 426, 2003-01 ,pp. :
Basal-bolus insulin superior to sliding scale insulin in T2DM
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Insulin detemir provides all-round results in T2DM
Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. :
Insulin glargine better value than NPH in T2DM
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :